Going?
>>SLOUGH, U.K., June 24, 2004 (PRIMEZONE) -- Xenova Group plc (London:XEN.L - News) (NasdaqNM:XNVA - News) will next week host an Investor/Analyst R&D Day in both New York and London. The event in New York will be held at 08:30 a.m. EDT on Tuesday 29 June and the London event will take place at 08:30 a.m. BST on Friday 2 July. The New York R&D Day will be webcast and can be accessed by going to the Company website at xenova.co.uk. Xenova's senior management and senior scientific staff will discuss the Company's clinical development programmes, with a focus on TransMID(tm), the Company's candidate for treatment of Glioblastoma Multiforme, and will also include presentations on TA-CD and TA-NIC, the Company's addiction vaccines, the Novel DNA Targeting Agents, and XR303, a candidate for the treatment of pancreatic cancer.
To attend the event in New York, please contact Lee Stern at The Trout Group at 212-477-9007 x22. For the London event, contact Mo Noonan at Financial Dynamics at 020 7831 3113.<<
snip
Cheers, Tuck |
